Evaluation of QuantiFERON-TB Gold Plus on Liaison XL in a Low-Tuberculosis-Incidence Setting.

De Maertelaere, E; Vandendriessche, S; Verhasselt, B; Coorevits, L; André, E; Padalko, E; Boelens, J

De Maertelaere, E; Vandendriessche, S; Verhasselt, B; Coorevits, L; André, E; Padalko, E; Boelens, J.

Afiliación

De Maertelaere E; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
Vandendriessche S; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium stien.vandendriessche@uzgent.be.
Verhasselt B; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
Coorevits L; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
André E; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
Padalko E; Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
Boelens J; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.

J Clin Microbiol ; 58(4)2020 03 25.

Article en En | MEDLINE | ID: mdl-32024727

Asunto(s)

Tuberculosis Latente; Tuberculosis; Humanos; Incidencia; Ensayos de Liberación de Interferón gamma; Prueba de Tuberculina; Tuberculosis/diagnóstico; Tuberculosis/epidemiología

Palabras clave

LTBI; Liaison XL; QuantiFERON-TB Gold Plus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / Tuberculosis Latente Tipo de estudio: Diagnostic_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Microbiol Año: 2020 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google